Peter Lamb Exelixis, Inc. (EXEL) insider trading activity

Peter Lamb is EVP, Scientific Strategy & CSO of EXELIXIS, INC.. Currently has a direct ownership of 410,958 shares of EXEL, which is worth approximately $10.9 Million. The most recent transaction as insider was on Dec 15, 2022, when has been sold 20,000 shares (Common Stock) at a price of $15.88 per share, resulting in proceeds of $317,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 411K

0% 3M change

0% 12M change

Total Value Held $10.9 Million

Peter Lamb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2022	SELL Open market or private sale	$317,600 $15.88 p/Share	20,000 Reduced 4.64%	410,958 Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	$84,000 $4.2 p/Share	20,000 Added 4.44%	430,958 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$119,927 $16.71 p/Share	7,177 Reduced 1.72%	410,958 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$154,234 $21.49 p/Share	7,177 Reduced 1.69%	418,135 Common Stock
Aug 03 2022	BUY Grant, award, or other acquisition	-	28,950 Added 6.37%	425,312 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$122,950 $20.08 p/Share	6,123 Reduced 1.52%	396,362 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	59,490 Added 12.88%	402,485 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$375,090 $18.59 p/Share	20,177 Reduced 5.56%	342,995 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$78,982 $17.0 p/Share	4,646 Reduced 1.26%	363,172 Common Stock
Dec 15 2021	SELL Open market or private sale	$828,400 $17.44 p/Share	47,500 Reduced 11.57%	363,172 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	18,741 Added 4.85%	367,818 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$294,975 $6.21 p/Share	47,500 Added 10.37%	410,672 Common Stock
Nov 15 2021	SELL Open market or private sale	$859,275 $18.09 p/Share	47,500 Reduced 10.35%	411,240 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$1,125,150 $18.1 p/Share	62,163 Reduced 15.12%	349,077 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$294,975 $6.21 p/Share	47,500 Added 9.38%	458,740 Common Stock
Oct 15 2021	SELL Open market or private sale	$1,041,200 $21.92 p/Share	47,500 Reduced 10.35%	411,240 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$294,975 $6.21 p/Share	47,500 Added 9.38%	458,740 Common Stock
Sep 30 2021	SELL Payment of exercise price or tax liability	$148,062 $20.63 p/Share	7,177 Reduced 1.72%	411,240 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	28,950 Added 6.47%	418,417 Common Stock
Sep 15 2021	SELL Open market or private sale	$971,850 $20.46 p/Share	47,500 Reduced 10.87%	389,467 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$294,975 $6.21 p/Share	47,500 Added 9.8%	436,967 Common Stock
Aug 16 2021	SELL Open market or private sale	$1,014,200 $18.44 p/Share	55,000 Reduced 12.37%	389,467 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$104,500 $1.9 p/Share	55,000 Added 11.01%	444,467 Common Stock
Jul 15 2021	SELL Open market or private sale	$1,048,200 $17.47 p/Share	60,000 Reduced 13.35%	389,467 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$114,000 $1.9 p/Share	60,000 Added 11.78%	449,467 Common Stock

Peter Lamb

EVP, Scientific Strategy & CSO

Alameda, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Value

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL

Account